Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: OPTIMUM

No higher early MS relapse frequency after stopping ponesimod

Presented By
Prof. Ludwig Kappos, University of Basel, Switzerland
Trial
Phase 3, OPTIMUM
Conference
EAN 2021

18 August, 2021 10:32

Superior effect of ponesimod versus teriflunomide on clinical disease activity and MRI-based outcomes

Trial
Phase 3, OPTIMUM
Conference
ECF 2020

16 December, 2020 10:22

Safety and efficacy of cladribine, glatiramer acetate, and more

Trial
CLASSIC-MS, OPTIMUM
Conference
MS Virtual 2020

25 November, 2020 16:55

Two trials comparing relapsing MS treatments

Presented By
Dr L. Kappos & Dr T. Sprenger
Trial
Phase 3, OPTIMUM, ASCLEPIOS
Conference
EAN 2020

10 September, 2020 12:21
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy